Inflammation and LDL Reduction

Curr Vasc Pharmacol. 2023;21(1):69-70. doi: 10.2174/1570161120666221004150503.

Authors

Vasilios Gabriel Athyros¹, George Sfikas², Charalambos Koumaras²

Affiliations

¹ Second Prop. Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, 55132, Greece.
² 424 Military Hospital, Thessaloniki, 564 29, Greece.

PMID: 36200194
DOI: 10.2174/1570161120666221004150503

No abstract available

Publication types

Comment

MeSH terms

Humans
Inflammation*
Lipoproteins, LDL*

Substances

Lipoproteins, LDL